Philippe Clevenbergh
Impact in
- Virology top 1%
- HIV Research and Treatment
-
- Antibiotic Use and Resistance
Papers in
-
- HIV/AIDS drug development and treatment 18
- HIV/AIDS Research and Interventions 12
- Antimicrobial Resistance in Staphylococcus 3
- Virology 13
- HIV Research and Treatment 10
- Rabies epidemiology and control 3
- Co-authors
- P. Dellamonica (16 shared papers)J. Durant (12 shared papers)Philippe Halfon (4 shared papers)N Montagne (5 shared papers)CAB Boucher (2 shared papers)Pere Simonet (2 shared papers)Pascal Del-Giudice (1 shared paper)R. Garraffo (4 shared papers)
- Journals
- PLoS ONE (3 papers)HIV Clinical Trials (3 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (3 papers)AIDS (3 papers)Clinical Infectious Diseases (3 papers)
- Partner nations
- BelgiumFranceUnited States
In The Last Decade
Philippe Clevenbergh
61 papers receiving 2.2k citations
Philippe Clevenbergh's Hit Papers
Peers
Comparison fields: 5 of 118
- Virology 693
- Applied Microbiology and Biotechnology 198
- Infectious Diseases 1.3k
- Molecular Medicine 298
- Critical Care and Intensive Care Medicine 69
Countries citing papers authored by Philippe Clevenbergh
This map shows the geographic impact of Philippe Clevenbergh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Clevenbergh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Clevenbergh more than expected).
Fields of papers citing papers by Philippe Clevenbergh
This network shows the impact of papers produced by Philippe Clevenbergh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Clevenbergh. The network helps show where Philippe Clevenbergh may publish in the future.
Co-authors
The 25 scholars most cited alongside Philippe Clevenbergh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Drug-resistance genotyping in HIV-1 therapy: the VIRAD APT randomi sed controlled trial Hit paper breakdown → | 1999 | 560 |
| 2 | Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial Hit paper breakdown → | 2020 | 335 |
| 3 | 1999 | 204 | |
| 4 | 2000 | 182 | |
| 5 | 2000 | 98 | |
| 6 | 2000 | 91 | |
| 7 | 2002 | 76 | |
| 8 | 1997 | 71 | |
| 9 | 2006 | 61 | |
| 10 | 2006 | 54 | |
| 11 | 2002 | 41 | |
| 12 | 2014 | 34 | |
| 13 | 2021 | 30 | |
| 14 | 2004 | 29 | |
| 15 | 2000 | 28 | |
| 16 | 2003 | 23 | |
| 17 | 2020 | 23 | |
| 18 | 2020 | 19 | |
| 19 | 2006 | 19 | |
| 20 | 2009 | 17 |
About Philippe Clevenbergh
Philippe Clevenbergh is a scholar working on Infectious Diseases, Virology, Epidemiology, Surgery and Public Health, Environmental and Occupational Health, having authored 69 papers that have together received 2.3k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (18 papers), HIV/AIDS Research and Interventions (12 papers), HIV Research and Treatment (10 papers), Streptococcal Infections and Treatments (4 papers), Rabies epidemiology and control (3 papers), Hepatitis C virus research (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers) and Brucella: diagnosis, epidemiology, treatment (3 papers). The work is most often cited by research in Virology (693 citations), Applied Microbiology and Biotechnology (198 citations), Infectious Diseases (1.3k citations), Molecular Medicine (298 citations) and Critical Care and Intensive Care Medicine (69 citations). Philippe Clevenbergh has collaborated with scholars based in Belgium, France and United States. Frequent co-authors include P. Dellamonica, J. Durant, Philippe Halfon, N Montagne, CAB Boucher, Pere Simonet, Pascal Del-Giudice, R. Garraffo, Marc Struelens and P. Del Giudice. Their work appears in journals such as PLoS ONE, HIV Clinical Trials, JAIDS Journal of Acquired Immune Deficiency Syndromes, AIDS and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.